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Article points
1. The acute stages of the 
COVID-19 pandemic, 
particularly the first wave, 
saw widespread reassignment 
of diabetes inpatient 
specialist nurses (DISNs) 
to cover general wards.
2. The services of DISNs have 
become pertinent in managing 
the convoluted pathology of 
COVID-19-related diabetes. 
Careful planning is needed to 
preserve diabetes inpatient 
services during future waves 
of COVID-19 and once the 
virus becomes endemic.
3. Provisions should be made 
for staff including access to 
and uptake of mental health 
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This study aimed to explore the impact of COVID-19 and associated redeployment on 
diabetes inpatient specialist nurses (DISNs) and the wellbeing support offered to them 
during the pandemic in the UK. The DISN UK Group, in conjunction with Diabetes 
UK, sent out a Freedom Of Information (FOI) request to 229 NHS Trusts and an online 
survey to UK DISNs to understand the impact of the pandemic on diabetes inpatient 
services and specialist nurses during both the first and the second COVID-19 waves. 
Forty-one NHS Trusts responded to the FOI request and 24 DISNs participated in 
the online survey. The online survey reported that 50% of inpatient team members 
were reduced and disbanded to work on the wards during the first wave of COVID-19 
(March–May 2020), compared with 23% in the second wave (December 2020 to 
May 2021). In the FOI request analysis, 36 out of 41 Trusts reported having dedicated 
DISN(s). Half of the Trusts with dedicated DISNs redeployed their staff during the first 
wave of COVID-19 compared with 30% of Trusts during the second wave. Almost all 
Trusts had provisions for staff to access mental health and wellbeing services. These 
findings suggest that careful planning is needed to preserve diabetes inpatient nurses’ 
services to support and manage people with diabetes and the convoluted pathology 
of COVID-19-related diabetes during future waves of COVID-19. Provisions should be 
made for staff including access to and uptake of mental health and wellbeing services 
to deal with work-related stress.
Over the last few decades, key stakeholders have worked tirelessly to raise awareness of the need for diabetes inpatient 
services, given that hospital bed occupancy by 
people with diabetes remains stable at around 20% 
(Diabetes UK, 2017; NHS Digital, 2020). However, 
almost one fifth (18%) of hospital sites in the UK 
still have no dedicated diabetes inpatient specialist 
nurse (DISN), according to the 2019 National 
Inpatient Diabetes Audit (NHS Digital, 2020).
In 2020, with the surge in COVID-19 infections, 
healthcare systems experienced increased demand 
for inpatient care (McCabe et al, 2020). As a result, 
many healthcare workers, including DISNs, were 
redeployed to work on general wards, as part of 
the NHS plan to address staffing issues and the 
unprecedented wave of hospitalised patients with 
COVID-19 (Rayman et al, 2020). This further 
stifled the delivery of care for inpatients with 
diabetes, who were also disproportionately affected 
by COVID-19 (Holman et al, 2020).
An online survey of 1829 diabetes nurses 
undertaken by the Foundation of European Nurses 
in Diabetes revealed substantial interruption 
in clinical diabetes services (Forde et al, 2021). 
Anecdotal evidence suggested that, in the UK, most 
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diabetes nurses were redeployed, leaving only a few 
diabetes nurses to care for inpatients.
Several studies have reported the physical and 
mental health effects of the COVID-19 pandemic 
on healthcare professionals. This includes the 
worry about dealing with a highly infectious virus 
(Wu et al, 2020), wearing of personal protective 
equipment (Vindrola-Padros et al, 2020), anxiety 
about working in unfamiliar settings (Sykes and 
Pandit, 2021), rapidly changing clinical protocols 
and guidelines (Maben and Bridges, 2020), and 
redeployment due to staff shortages (Vindrola-
Padros et al, 2020). In addition to these, the limited 
number of DISNs working in diabetes were at an 
increased risk of stress due to growth in demand 
secondary to the glycaemic complications of 
COVID-19 (Rubino et al, 2020).
The impact of the COVID-19 pandemic on 
DISNs in the UK is not well documented. For 
example, it is not known what proportion of DISNs 
in the UK were redeployed during the pandemic, 
and the possible implications of this on inpatient 
diabetes care are not well understood. It is also 
not clear whether, or the extent to which, DISN 
wellbeing was supported during the COVID-19 
pandemic. This is important in identifying gaps 
in staffing and staff wellbeing, in order to develop 
appropriate resources and services. Our study aim, 
therefore, was to explore the impact of COVID-19, 
and associated redeployment, on diabetes inpatient 
specialist nurse services in the UK.
Methodology
The DISN UK Group, in collaboration with 
Diabetes UK, developed two set of questionnaires to 
understand the impact of the pandemic on diabetes 
inpatient services and specialist nurses during both 
the first and the second COVID-19 waves.
In the first survey by the DISN UK Group, a 
Freedom of Information (FOI) request was emailed 
to 229 NHS Trusts across the UK in April 2021. 
As this was an FOI request, we did not require an 
ethical review board regulation. FOI requests have 
existing structures in place that satisfy ethical values 
and considerations (Walby and Luscombe, 2018). 
The following information was asked:
l The number of dedicated DISNs (including 
whole time equivalents [WTE; a division of the 
number of required hours for a role by the fullt-
time equivalent of 37.5 hours per week]).
l Whether COVID-19 risk assessments were 
available.
l Redeployment during the first and second waves 
of the pandemic.
l The referral and support available for the mental 
health and wellbeing of DISNs.
Concurrently, Diabetes UK conducted a short, 
online, open-access survey for DISNs in the UK via 
social media to gain insight into the following:
l The impact of the pandemic on DISN staffing 
numbers.
l Available medical team support during the first 
and second COVID-19 waves.
l Available dedicated discharge services for patients.
l The provision of blood glucose meters for patients, 
especially those managed on steroid therapy.
These two questionnaires are detailed in Box 1 
and Box 2 (overleaf).
Participants’ responses were exported into 
Microsoft Excel and analysed using descriptive 
statistics, and grouped into the following categories: 
dedicated DISN workforce and risk assessment; 




Of the 229 FOI requests sent, only 41 respondents 
provided answers to the information requested. 
Box 1. DISN UK Group Freedom of Information questionnaire.
1. How many dedicated whole/full-time equivalent (WTE/FTE) Diabetes Inpatient 
Specialist Nurses do you have in your Trust?
2. Of these, how many were redeployed due to the COVID-19 pandemic?
First wave:
Second wave:
3. Do you have any provisions in your Trust for mental health and wellbeing?
a. If yes, which service?
4. Has any of the DISN team been referred or self-referred to the mental health and 
wellbeing services?
a. If yes, how many?
5. How many acute beds do you have in your Trust (excluding maternity and 
paediatrics)?
6. Have all the Diabetes Inpatient Specialist Nurses been COVID risk-assessed?
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The others that responded were commissioning 
groups, which did not hold the relevant information 
required.
Dedicated DISN workforce and risk assessment
Thirty-six of 41 Trusts had dedicated DISN(s), and 
all of these staff were assessed to minimise potential 
risk to themselves and patients. One Trust had a 
new staff member who was yet to be risk-assessed.
The total DISN WTE provided by these Trusts 
was 147.6, but the range was vast: between 1.0 and 
11.8 WTE. Of the Trusts which did not have a 
dedicated DISN, diabetes inpatient services were 
shared among the diabetes specialist nurse (DSN) 
rota (n=3) or provided by DISNs from another Trust 
(n=1). Only one Trust declined to respond to this 
question due to confidentiality reasons.
Within those Trusts with a dedicated DISN, the 
DISN-to-bed ratio (i.e. the number of acute beds 
attended by one DISN WTE) ranged from 1:82 
to 1:600, demonstrating significant differences 
in potential workload. Six Trusts had one DISN 
for more than 300 beds and two of these had one 
DISN for more than 500 beds. The distribution of 
DISN-to-bed ratios is shown in Figure 1 (overleaf).
Redeployment during COVID-19
Eighteen Trusts (50%) redeployed DISN staff (0.2–
5.0 WTE) during the first wave of the pandemic 
(March to May 2020), while the remaining 18 did 
not redeploy any DISN. Of those that redeployed 
DISNs, this was equivalent to a total of 33.7 WTE, 
with one Trust redeploying all its staff.
During the second COVID-19 wave (December 
2020 to May 2021), 11 Trusts redeployed a total 
of 19.9 DISN WTE (including two Trusts that 
redeployed all their DISNs), but the majority (n=26; 
70%) did not redeploy any staff. Eight  Trusts 
Box 2. Diabetes UK inpatient nurse survey.
1. Are you currently working as a Diabetes Inpatient Specialist Nurse (DISN)? Yes or No
2. Which country in the UK do you work in? Select all that apply
(i) England  (ii) Scotland  (iii) Wales  (iv) Northern Ireland
3. Were there changes to your inpatient team staffing numbers during the first wave of the COVID-19 
pandemic (March–May 2020)? Select below:
(i) Expanded – with help from community team  (ii) Reduced – to allow some ward working  (iii) Disbanded 
– to work on the wards  (iv) No change  (v) Other
4. What was the reduction in whole time equivalent (WTE) hours?
5. Was there a reduction in available support from medical staff during the first wave of the pandemic (March–
May 2020)?
6. What were medical staff covering instead?
7. Were there changes to your inpatient team staffing numbers during the second wave of the COVID-19 
pandemic (December 2020–present)?
8. What was the reduction in whole time equivalent (WTE) hours?
9. Has there been a reduction in available support from medical staff during the second wave of the pandemic 
(December 2020–present)?
10. What are medical staff covering instead?
11. Has your inpatient team adopted 7-day working?
12. Does your team offer a dedicated discharge follow-up service?
13. What format does your dedicated discharge service use?
14. How confident would you be that you would have enough meters to provide for patients if there were an 
increased demand for meters and test strips for people at home on dexamethasone?
15. How are your meters supplied to the hospital?
16. Will your team have the time to ensure people are safely trained on meter use before discharge?
17. How will you be able to ensure people are safely trained on meter use before discharge?
Developing a tool The 
workload of the diabetes 
specialist nurse workforce 
in the UK
This study into the workload 
and productivity of diabetes 
specialist nurses reveals a 
workforce under increasing 
strain, and identifies a 
number of issues that could 
be addressed to improve care.
Journal of Diabetes Nursing 
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redeployed DISNs during both waves; nine 
redeployed during the first wave only; four 
redeployed during the second wave only; and 14 did 
not redeploy any DISNs during either wave.
Mental health and wellbeing services available 
for DISNs during COVID-19
All of the 41 Trusts except one, which did not share 
its information, reported having provisions for staff 
to access mental health and wellbeing services. 
Identified services included Employee Assistance 
Programmes (EAPs); Mental Health First Aid; Trust 
counselling and psychology services; wellbeing 
webinars; Vivup (an employee benefits provider 
specialising in health and wellbeing), Health 
Assured, Care First; and access to mindfulness and 
meditation, such as yoga, Reiki, etc.
We enquired whether DISNs were signposted to 
mental and wellbeing services at their workplaces 
during the pandemic. Only seven Trusts responded 
that their DISNs were referred to access available 
mental health and wellbeing services; the majority 
did not disclose this information on the grounds of 
confidentiality.
Diabetes UK questionnaire results
There were 26 respondents to the Diabetes UK 
questionnaire, of whom 24 were DISNs and two 
were excluded as they appeared to be duplicates 
from the same Trust. The majority (88%, n=21) 
were from England, 8% (n=2) were from Scotland 
and 4% (n=1) were from Wales and none from 
Northern Ireland.
Changes to inpatient staffing levels, reduction in 
WTE and adoption of seven-day working schedule
The survey responses concerning changes to 
inpatient staffing numbers are summarised in 
Figure  2. It shows twice as many inpatient team 
members (50%; n=13) were reduced and disbanded 
to work on the wards during the first wave of 
COVID-19 than in the second wave (23%; n=6). 
Nearly half of the respondents (46%; n=12) reported 
no changes to their staffing numbers during the 
Figure 1. Distribution of diabetes inpatient specialist nurse (DISN) whole time equivalent (WTE) 
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Number of beds per DISN WTE
Figure 2. Changes to inpatient team staffing numbers.
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second COVID-19 surge as compared to the first 
surge. The inpatient teams were expanded with 
support from community teams during both waves, 
which may have impacted on community diabetes 
service provision.
The reduction in WTE (range from 0.1 to more 
than 3.0 WTE) occurred more frequently during 
the first wave than the second wave, as reported in 
Figure 3.
Additionally, the survey asked how many of 
the inpatient teams operated a seven-day working 
schedule during the pandemic. Prior to the start 
of the COVID-19 outbreak, before March 2020, 
seven (27%) of the 26 responding inpatient 
teams operated a seven-day plan. During the first 
COVID-19 wave, only five respondents (19%) 
adopted a 7-day working schedule, and this number 
increased to eight (31%) during the second wave.
Reduction in medical support
The inpatient team reported a roughly 60% 
reduction in available medical support during both 
COVID-19 waves. Half of the medics were not 
available due to sickness or staff shielding. Most 
of the consultants (80% on average) were sent to 
cover general medical wards, and just under 20% of 
both junior doctors and consultants were seconded 
to intensive care units. A few of the junior doctors 
were also asked to support general wards. Figure 4 
compares medical staff coverage in both the first 
and the second COVID-19 waves.
Dedicated discharge services
Approximately 60% (n=16) of the inpatient teams 
reported having a dedicated discharge follow-up 
service, while the remaining 40% (n=10) had none. 
All of the inpatient teams who responded (n=16) 
offer telephone follow-up appointments, and almost 
half (44%; n=7) provide face-to-face follow-up 
as well. Generally, 25% of the participants (n=4) 
deliver follow-up via remote formats.
The Diabetes UK survey also looked at the 
availability and supplies of blood glucose meters to 
Figure 3. Reduction in DISN whole time equivalents during the COVID-19 waves.
Figure 4. Medical team availability during the COVID-19 waves.
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hospital and to people on dexamethasone at home, 
and whether staff were confident they could train 
patients safely before discharge. Details of the 
responses are in Table 1.
Most hospitals receive and negotiate the number 
of meters needed directly from the companies 
that produce them, and none are procured by the 
hospitals themselves. In times of increasing demand, 
especially for people on dexamethasone at home, 
over 80% of the inpatient teams felt confident 
that enough meters would be available; however, 
only 50% felt they would have time to safely train 
patients before discharge. The training was mostly 
conducted face-to-face, but around a third of 
respondents (35%) reported using online training 
videos for their patients.
Discussion
These surveys have provided insight into the impact 
of the COVID-19 pandemic on diabetes inpatient 
specialist services in the UK. Although the number 
of participants is relatively small, the study results 
have highlighted the changes to diabetes inpatient 
specialist teams’ staffing numbers and a reduction 
of dedicated DISN hours during both COVID-19 
waves in the UK. Some Trusts in the UK do not 
have a dedicated DISN team but they usually share 
the work among their DSN rota. The Joint British 
Diabetes Societies for Inpatient Care (2019) have 
stressed the worrying shortage of DISNs in the UK, 
which accounts for why about 30% of inpatients 
with diabetes are not reviewed by a dedicated 
DISN team.
Our findings are in line with the National 
Diabetes Inpatient Audit in 2019, which reported 
that a sixth of hospitals still have no DISNs, 
though the number of DISN hours per patient 
had gradually improved since the years 2015 and 
2017 (NHS Digital, 2020). There is a need for 
more dedicated inpatient specialist teams to match 
up the number of beds occupied by people with 
diabetes in the hospital to promote good inpatient 
outcomes. This has been further highlighted by the 
NHS Long Term Plan, which states that hospitals 
should offer expanded access to diabetes inpatient 
specialist nursing teams to reduce inpatients’ length 
of stay, enhance recovery and prevent potential 
readmissions (NHS, 2019).
During the COVID-19 waves, redeployment of 
healthcare professionals was used as an approach to 
Question Response (n; %)
Confidence regarding 
availability of meters 
during increased 








Not at all confident
0 (0%)
Supply of meters to the 
hospitals
Set amount delivered 
monthly by meter 
companies
1 (4%)
Meters delivered by 
the companies but 




by the companies 





supplied at the 
hospital for people 




by the hospital and 
prescriptions given to 
individuals for collection 
from pharmacy
0 (0%)
Time available to safely 















Table 1. Glucose meter availability and supply and training of patients on meter use before discharge.
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address shortages and capacity concerns (Vindrola-
Padros et al, 2020). Our study showed that many 
Trusts both redeployed their DISNs and had 
severely reduced medical support during the 
pandemic, especially during the first wave. The 
National Diabetes Inpatient COVID-19 Response 
Group, created in the last week of March 2020, 
reported similar findings in one of its Diabetes UK 
position statements (Rayman et al, 2020). It 
remarked that most diabetes teams, including 
inpatient specialist nurses, were redeployed to 
support general ward care.
Redeployment and disruption in clinical diabetes 
services further impacted on the care that inpatients 
with diabetes required during the pandemic, 
which relates to the findings of the pan-European 
survey of diabetes specialist nurses undertaken by 
the Foundation of European Nurses in Diabetes 
COVID-19 consortium (Forde et al, 2021).
COVID-19 infection has been associated with 
increased risk of new-onset diabetes (Rubino et al, 
2020) and increased hyperglycaemic episodes from 
severe infection (Li et al, 2020). In addition, most 
studies have reported that people with diabetes 
are at increased risk of severe COVID-related 
infection and mortality (Bornstein et al, 2020; 
Holman et al, 2020). In people admitted with 
COVID-19, the use of dexamethasone has been 
accepted as a possible treatment for the coronavirus 
infection. The RECOVERY trial demonstrated that 
once-daily dexamethasone 6 mg reduces mortality 
in patients with COVID-19 who are on respiratory 
support (RECOVERY Collaborative Group, 
2021). However, this treatment has the potential 
to further trigger steroid-induced hyperglycaemia, 
which can be difficult to manage, coupled with 
COVID-induced insulin resistance and impaired 
insulin production (Rayman et al, 2020). As a 
result of all these factors, more patients treated for 
coronavirus infection are requiring blood glucose 
monitoring and close follow-up, even at discharge, 
for hyperglycaemia management.
Some hospitals do not have dedicated discharge 
services for patients to influence timely and 
safe discharge. The NHS England launching of 
COVID-19 virtual ward models in 2021, as part 
of the response to safely discharge patients with 
coronavirus, can be useful to support diabetes 
discharge services (NHS England and NHS 
Improvement, 2021). Diabetes specialist teams 
can adapt the COVID-19 virtual wards guidance 
to agree on local pathways to provide follow-up 
diabetes care for people with diabetes to prevent 
further rehospitalisation (National Inpatient 
Diabetes COVID-19 Response Group, 2021).
The effects of the COVID-19 era on the mental 
health and wellbeing of all healthcare professionals 
have been well researched (Sykes and Pandit, 2021; 
Phiri et al, 2021). In our results, most Trusts had 
provisions for mental health and wellbeing services 
for their staff, but it is unclear whether people 
were accessing these services. It is noteworthy that 
individuals may require a degree of self-awareness 
and motivational energy to engage with these 
wellbeing services, if available. Diabetes inpatient 
teams should be encouraged to access services 
to support their mental health and emotional 
wellbeing, to cope with the stress from managing 
challenging cases of COVID-related diabetes 
pathology. The British Psychological Society (2020) 
also provided guidance for healthcare managers 
to practise visible leadership and demonstrate an 
effective communication strategy to support staff 
wellbeing during the pandemic. This guideline can 
be a useful resource for managers.
This study is limited by a small sample size and 
low response rate, as few of the NHS Trusts and 
DISNs responded. There is also a possibility that 
some people who responded to the Diabetes  UK 
survey may have been from the same Trusts that 
answered the FOI request, resulting in some 
redundancy of data within the results.
Conclusion
The services of DISNs have become pertinent 
in managing the convoluted pathology of 
COVID-19-related diabetes. There should be 
provisions for staff including access to and uptake 
of mental health and wellbeing services to deal 
with work-related stress. Careful planning is 
needed to preserve diabetes inpatient services 
during future waves of COVID-19, and 
consideration should be given to the potential 
increase in diabetes service provision once 
COVID-19 is no longer a pandemic but remains 
endemic among the general population, in order 
to promote good care outcomes for people with 
diabetes and their safe discharge. n
Diabetes specialist nurses: 
Empowering patient self-
management, increasing 
patient safety and 
satisfaction
Jessica Lawler summarises her 
recent literature review on 
diabetes specialist nursing and 
argues for the value of DSNs 
in diabetes services.
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